[Methylphenidate augmentation of fluvoxamine for treatment-resistant depression: a case report and review literature].


Methylphenidate and other psychostimulants have received substantial attention for the management of depression in patients with medical co-morbidities as well as for the symptomatic palliation of various neuropsychiatric disorders. Despite having been of little use in the first-line treatment of depressive disorders, some evidence does suggest that they… (More)

1 Figure or Table


  • Presentations referencing similar topics